Anti-NSE [NSEP2]
Invented by Ayham Alnabulsi at Vertebrate Antibodies Limited
Catalogue Number | 151866 |
Applications | ELISA IHC WB |
Antigen/Gene or Protein Targets | Gamma-isozyme of human enolase (NSE) |
Reactivity | Human |
Relevance | Neuron specific enolase (NSE, or gamma-isozyme of enolase) is found at elevated concentrations in plasma in certain neoplasias, including paediatric neuroblastoma and small cell lung cancer. |
Host | Mouse |
Immunogen | Ovalbumin-conjugated synthetic peptides corresponding to human NSE amino acid sequence:NSE-P1: aa’s 416-433 - LGDEARFAGHNFRNPSVL |
Positive Control | IHC: formalin-fixed, paraffin-embedded nerve tissue sectionswestern blot: ?-isozyme of human enolase; 50-100 ng per lane |
Subclass | IgG1 kappa |
Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM + 60 ml Fetal Bovine Serum plus 3ml L-Glutamine + 3ml of Penicillin -Streptomycin. |
Strain | Balb/c |
Notes | Not reactive with -isozyme of enolase |
Research Area | Cancer, Cell Type or Organelle Marker, Developmental Biology, Metabolism, Neurobiology, Stem Cell Biology |
Murray et al. 1993. J Clin Pathol. 46(11):993-6. PMID: 8254105.
Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies.
Europe PMC ID: 8254105
Duncan et al. 1992. J Immunol Methods. 151(1-2):227-36. PMID: 1629611.
A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences.
Europe PMC ID: 1629611
Murray et al. 1993. J Clin Pathol. 46(11):993-6. PMID: 8254105.
Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies.
Duncan et al. 1992. J Immunol Methods. 151(1-2):227-36. PMID: 1629611.
A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences.